Although TP53 is a biologically important gene and is often affected in CHIP, its clinical relevance beyond myeloid neoplasms (1, 5) and cancer treatment (1, 2, 6) is unclear due to an inadequate evaluation. This evidence concerns the gene TP53 and myeloid neoplasm.